Abstract:Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications in diabetes. Previous studies have shown that chronic neuroinflammation was associated with DPN. However, further research is needed to investigate the exact immune molecular mechanism underlying the pathogenesis of DPN. Expression profiles were downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were screened by R software. After functional enrichment analysis of DEGs, a protein–protein interaction (PPI) network analysis was performed. The CIBERSORT algorithm was used to evaluate the infiltration of immune cells in DPN. Next, the least absolute shrinkage and selection operator (LASSO) logistic regression and support vector machine-recursive feature elimination (SVM-RFE) algorithms were applied to identify potential DPN diagnostic markers. Finally, the results were further validated by qRT-PCR. A total of 1308 DEGs were screened in this study. Enrichment analysis identified that DEGs were significantly enriched in immune-related biological functions and pathways. Immune cell infiltration analysis found that M1 and M2 macrophages, monocytes, resting mast cells, resting CD4 memory T cells and follicular helper T cells were involved in the development of DPN. LTBP2 and GPNMB were identified as diagnostic markers of DPN. qRT-PCR results showed that 15 mRNAs, including LTBP2 and GPNMB, were differentially expressed, consistent with the microarray results. In conclusion, LTBP2 and GPNMB can be used as novel candidate molecular diagnostic markers for DPN. Furthermore, the infiltration of immune cells plays an important role in the progression of DPN.

Research progress in high-mobility group box-1 and diabetic peripheral neuropathy

High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications

High mobility group box 1 in diabetic nephropathy

The role of high mobility group box-1 on the development of diabetes complications: A plausible pharmacological target

Expression and significance of high-mobility group box 1 in pancreatic tissue of NOD mice

Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy

Progress in the treatment of diabetic peripheral neuropathy

Research Progress on Mechanism of Acupuncture in Treating Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathy based on Schwann cell injury: mechanisms of cell death regulation and therapeutic perspectives

How inflammation dictates diabetic peripheral neuropathy: An enlightening review

Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects

Beneficial Effect Of Tnf-Alpha Inhibition On Diabetic Peripheral Neuropathy

Relationship of high mobility group boxl and inflammation

Identification of Immune Infiltration and the Potential Biomarkers in Diabetic Peripheral Neuropathy through Bioinformatics and Machine Learning Methods

High mobility group box 1 in the central nervous system: regeneration hidden beneath inflammation

High mobility group box 1 and kidney diseases (Review)

HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target

HMGB1 in Development and Diseases of the Central Nervous System

The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases

Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy

Beneficial effect of TNF-α inhibition on diabetic peripheral neuropathy